Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Retinal Disorders Markets 2017: Treatment, Marketed Drugs, Pipeline - Research and Markets

Research and Markets
Posted on: 09 Nov 17

The "Retinal Disorders" report has been added to Research and Markets' offering.

A range of disorders, some of which share similar underlying pathologies, can affect the retina and lead to progressively worsening vision and eventual blindness. The retina is the layer of light-sensitive tissue at the back of the eye that converts light into impulses to the brain via the optic nerve. A common feature of certain retinal disorders is abnormal growth of blood vessels in the macula, which can be effectively treated by drugs targeting vascular endothelial growth factor. These discrete indications are wet age-related macular degeneration, diabetic retinopathy with and without diabetic macular edema, and macular edema from retinal vein occlusion.

Key Topics Covered:

1 TREATMENT: RETINAL DISORDERS

  • Executive Summary
  • Primary Research Methodology
  • Disease Definition and Diagnosis
  • Patient Segmentation
  • Current Treatment Options
  • Prescribing Trends
  • Unmet Needs in Retinal Disorders

2 MARKETED DRUGS: RETINAL DISORDERS

  • Executive Summary
  • Product Overview
  • Product profile: Avastin
  • Product profile: Eylea
  • Product profile: Lucentis
  • Product profile: Ozurdex

3 PIPELINE: RETINAL DISORDERS

  • Executive Summary
  • Clinical Pipeline Overview
  • Product profile (late stage): Zuprata
  • Product profile (late stage): abicipar pegol
  • Product profile (late stage): brolucizumab
  • Product profile (late stage): squalamine

For more information about this report visit https://www.researchandmarkets.com/research/pjz56c/retinal_disorders

View source version on businesswire.com: http://www.businesswire.com/news/home/20171109005708/en/

Business Wire
www.businesswire.com

Last updated on: 09/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.